Please login to the form below

Not currently logged in
Email:
Password:

Dr Alan Joslyn becomes president and CEO of Oragenics

He will also serve on the company’s board of directors

Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board of directors.

Dr Joslyn was a founding partner of Lazarus Pharmaceuticals, and has served as chief executive officer at both Edusa Pharmaceuticals and Sentinella Pharmaceuticals.

Prior to this, he worked at Penwest Pharmaceuticals as the senior vice president of research and development, and has held senior drug development positions within Johnson & Johnson.

Dr Frederick Telling, chairman of Oragenics, said: “As Oragenics opens this new chapter, the board and I are confident that Dr Joslyn is the right person to lead the company forward.

“He has proven ability to create strategic clarity, drive innovation and ensure disciplined execution as well as a depth of experience from serving a large pharmaceutical company and smaller research oriented companies, with particular experience in gastrointestinal disease and lantibiotics.

“We believe that his passion for technology will help ensure that Oragenics continues to strive to deliver innovations that have a positive impact on people's lives.”

17th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics